Literature DB >> 25560493

Surgical treatment of gastric cancer in Japan, trend from standardization to individualization.

K Maruyama, H Katai.   

Abstract

Japan has a huge number of patients with gastric cancer and has developed various surgical treatments for this disease.This paper intends to introduce our strategies against gastric cancer. The Japanese Gastric Cancer Association was established in 1962. Its major purposes are promotion of basic and clinical researches and popularization of the latest knowledge and technologies. For the purposes, the association organized the annual scientific meeting and the nationwide registry by member hospitals, and published the Japanese Classification of Gastric Cancer (1) and the Treatment Guide Line (2). The nationwide registry reported that proportion of Stage-I cancer was 22.5% in 1963-66,which increased to 59.3% in 2008 (3,4,5). 11,261 patients with gastric resection were registered by 187 hospitals in 2008. 63 patients were died within 30 postoperative days and the direct death rate was 0.55%. 5 year survival rate (5YSR) was 37.5% for resected cases in 1963-66, which was improved to 70.1% in 2008. 5YSR was improved from 55.1% to 74.1% for Stage-II, and from 39.1% to 48.8% for Stage-III in the period. According to remarkable increase of early stage cancer, principle of surgical treatments was shifted from "€œextended and standardized surgery for radicality" €to "€œreasonable and individual surgery considering safety and quality of life"€. This trend produced a large variation in surgical treatments; namely 1) minimally invasive surgeries,2) function preserving surgeries, 3) optimal extent of lymph node dissection, and 4) aggressive but safe surgeries.Intention of this paper is to explain these procedures, the intentions, the indications, and the treatment results. Celsius.

Entities:  

Mesh:

Year:  2014        PMID: 25560493

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  8 in total

1.  Identification and functional characterization of long non-coding RNAs in human gastric cancer.

Authors:  Cheng-Yun Li; Ge-Yu Liang; Wen-Zhuo Yao; Jing Sui; Xian Shen; Yan-Qiu Zhang; Shu-Mei Ma; Yan-Cheng Ye; Zhi-Yi Zhang; Wen-Hua Zhang; Li-Hong Yin; Yue-Pu Pu
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

2.  The Role of No. 10 Lymphadenectomy for Advanced Proximal Gastric Cancer Patients Without Metastasis to No. 4sa and No. 4sb Lymph Nodes.

Authors:  Shibo Bian; Hongqing Xi; Xiaosong Wu; Jianxin Cui; Liangang Ma; Rong Chen; Bo Wei; Lin Chen
Journal:  J Gastrointest Surg       Date:  2016-03-03       Impact factor: 3.452

Review 3.  Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid.

Authors:  Noriaki Koizumi; Yoshinori Harada; Takeo Minamikawa; Hideo Tanaka; Eigo Otsuji; Tetsuro Takamatsu
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 4.  Comparison of Delta-Shape Anastomosis and Extracorporeal Billroth I Anastomosis after Laparoscopic Distal Gastrectomy for Gastric Cancer: A Systematic Review with Meta-Analysis of Short-Term Outcomes.

Authors:  Geng-Yuan Hu; Feng Tao; Ke-Wei Ji; Wei Wang
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

5.  Advantages of Distal Subtotal Gastrectomy over Total Gastrectomy in the Quality of Life of Long-Term Gastric Cancer Survivors.

Authors:  Oh Kyoung Kwon; Byunghyuk Yu; Ki Bum Park; Ji Yeon Park; Seung Soo Lee; Ho Young Chung
Journal:  J Gastric Cancer       Date:  2020-05-04       Impact factor: 3.720

6.  Long-term effects of gastrectomy in patients with spirometry-defined COPD and patients at risk of COPD: a case-control study.

Authors:  Hitoshi Saito; Koichiro Nomura; Shinji Abe; Takashi Motegi; Takeo Ishii; Kumiko Hattori; Yuji Kusunoki; Akihiko Gemma; Kozui Kida
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-29

Review 7.  Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?

Authors:  Rossella Reddavid; Silvia Sofia; Paolo Chiaro; Fabio Colli; Renza Trapani; Laura Esposito; Mario Solej; Maurizio Degiuli
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

8.  Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: a meta-analysis.

Authors:  Jun Du; Yangchao Shen; Wenwu Yan; Jinguo Wang
Journal:  World J Surg Oncol       Date:  2020-09-01       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.